Cannula, nasal, carbon dioxide sampling
ARTG ID: 399473 · Meditech Systems Asia Pacific Pty Ltd · Dispo-Med (Malaysia) Sdn Bhd · Class IIa · Started November 15, 2022
Good Name: Meditech Systems Asia Pacific Pty Ltd - Cannula, nasal, carbon dioxide sampling
- Risk Class
- Class IIa
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 399473
- Start Date
- November 15, 2022
- Effective Date
- November 15, 2022
- Country
- Malaysia
- Address
- No 3 Jalan Meteor u16/153A, Elmina Sekysen U16, Shah Alam, Salangor, 40160
Capnography nasal prongs are used to monitor carbon dioxide (CO2) in the respiratory gases. Its main development has been as a monitoring tool for use during anaesthesia and/or sedational procedures. The nasal cannula allows for the measurement taken at the end of a breath (exhaling), often referred to as end-tidal CO2. It helps to ascertain the patients respiratory effort. Single use device.
Access comprehensive regulatory information for Cannula, nasal, carbon dioxide sampling in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is registered under ARTG number 399473 and sponsored by Meditech Systems Asia Pacific Pty Ltd, manufactured by Dispo-Med (Malaysia) Sdn Bhd in Malaysia. The device registration started on November 15, 2022.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.